ETS1 and neoplasm: Dysregulated Ets1 expression induced a wide spectrum of progressive premalignant changes such as those induced by chemical carcinogens, activated oncogenes, or loss of tumor suppressors in well-established mouse models of squamous cell carcinogenesis.